Early Posthepatoportoenterostomy Predictors of Native Liver Survival in Biliary Atresia

Scott Nightingale1, Michael O Stormon, Edward V O'Loughlin

  • 1*Department of Gastroenterology, John Hunter Children's Hospital †Discipline of Paediatrics and Child Health, University of Newcastle, Newcastle, Australia ‡Transplant and Regenerative Medicine Centre §Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children ||Department of Paediatrics, University of Toronto, Toronto, Canada ¶Department of Gastroenterology, The Sydney Children's Hospital Network-Westmead #Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney **Department of Surgery, The Sydney Children's Hospital Network-Westmead, Sydney, Australia ††Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario ‡‡Department of Pediatrics and School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Canada §§Department of Gastroenterology, The Sydney Children's Hospital Network-Randwick, Sydney, Australia ||||Department of Paediatrics, University of Otago, Christchurch, New Zealand ¶¶Department of Surgery, The Sydney Children's Hospital Network-Randwick ##School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, Australia ***Division of General Surgery, Hospital for Sick Children †††Department of Surgery, University of Toronto, Toronto, Canada.

Insights

Biliary atresia (BA) infants needing liver transplantation (LT) can be identified by specific lab values post-hepatoportoenterostomy (HPE). Total bilirubin and albumin levels at 3 months post-HPE predict native liver survival at 2 years.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Neonatal Surgery

Background:

  • Biliary atresia (BA) is a severe neonatal liver disease.
  • Most infants with BA require liver transplantation (LT) after hepatoportoenterostomy (HPE).
  • Predicting native liver survival is crucial for managing BA patients.

Purpose of the Study:

  • To identify clinical and laboratory factors predicting 2-year native liver survival in BA infants post-HPE.
  • To establish prognostic indicators for BA patients undergoing HPE.

Main Methods:

  • Retrospective cohort study of 217 BA patients in Australia and Canada (1986-2009).
  • Analysis of clinical and laboratory data at 3 months post-HPE.
  • Univariate and multivariate logistic regression to identify predictors of native liver survival.

Main Results:

  • Serum total bilirubin (TB) and albumin levels at 3 months post-HPE were independent predictors of 2-year native liver survival.
  • Optimal cut-off values: TB <74 μmol/L and albumin >35 g/L.
  • Three distinct groups based on TB and albumin levels showed significantly different survival rates.

Conclusions:

  • Serum TB and albumin levels at 3 months post-HPE are valuable prognostic markers for BA patients.
  • Low albumin (<35 g/L) in non-jaundiced infants post-HPE indicates poor prognosis.
  • Poorer linear growth suggests a need for early nutritional support in select BA patients.
Abstract